Return On Equity of Inmune Bio, Inc. from 31 Dec 2020 to 30 Jun 2023
- Taxonomy & unit
- ratio: %
- Description
- Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
- Summary
-
Inmune Bio, Inc. quarterly and annual Return On Equity in % history and change rate from 31 Dec 2020 to 30 Jun 2023.
- Inmune Bio, Inc. Return On Equity for the quarter ending 30 Jun 2023 was -46%, a 1.5% increase year-over-year.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Inmune Bio, Inc. Quarterly Return On Equity (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| Q2 2023 | -46% | +0.7% | +1.5% | 01 Apr 2023 | 30 Jun 2023 |
| Q1 2023 | -43% | -0.04% | -0.1% | 01 Jan 2023 | 31 Mar 2023 |
| Q4 2022 | -41% | -2.7% | -7.2% | 01 Oct 2022 | 31 Dec 2022 |
| Q3 2022 | -43% | 01 Jul 2022 | 30 Sep 2022 | ||
| Q2 2022 | -47% | 01 Apr 2022 | 30 Jun 2022 | ||
| Q1 2022 | -43% | 01 Jan 2022 | 31 Mar 2022 | ||
| Q4 2021 | -38% | -6.6% | -21% | 01 Oct 2021 | 31 Dec 2021 |
| Q4 2020 | -31% | 01 Oct 2020 | 31 Dec 2020 |
Inmune Bio, Inc. Annual Return On Equity (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| 2022 | -41% | 01 Jan 2022 | 31 Dec 2022 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.